60
Views
11
CrossRef citations to date
0
Altmetric
Review

Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections

, , , , , & show all
Pages 465-480 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Liliana Rodrigues, Pedro Cravo & Miguel Viveiros. (2020) Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs. Expert Review of Anti-infective Therapy 18:8, pages 741-757.
Read now

Articles from other publishers (10)

Khushbu Sharma, Faraz Ahmed, Tarina Sharma, Abhinav Grover, Meetu Agarwal & Sonam Grover. (2023) Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade. ACS Omega 8:20, pages 17362-17380.
Crossref
T. Daniel Thangadurai & N. Manjubaashini. (2021) Progressions in chemical and biological analytes sensing technology based on nanostructured materials: A comprehensive review. Materials Science and Engineering: B 271, pages 115307.
Crossref
Diana Machado, Isabel Couto & Miguel Viveiros. (2019) Advances in the molecular diagnosis of tuberculosis: From probes to genomes. Infection, Genetics and Evolution 72, pages 93-112.
Crossref
Bruno Veigas, Pedro Pedrosa, Fábio F Carlos, Liliana Mancio-Silva, Ana Rita Grosso, Elvira Fortunato, Maria M Mota & Pedro V Baptista. (2015) One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care. Journal of Nanobiotechnology 13:1.
Crossref
Paulo Rabna, Jorge Ramos, Gema Ponce, Lilica Sanca, Morto Mané, Ana Armada, Diana Machado, Fina Vieira, Victor F. Gomes, Elisabete Martins, Raffaella Colombatti, Fabio Riccardi, João Perdigão, Joana Sotero, Isabel Portugal, Isabel Couto, Jorge Atouguia, Amabélia Rodrigues & Miguel Viveiros. (2015) Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa. PLOS ONE 10:5, pages e0127536.
Crossref
Pedro Pedrosa, Bruno Veigas, Diana Machado, Isabel Couto, Miguel Viveiros & Pedro V. Baptista. (2014) Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis. Tuberculosis 94:3, pages 332-337.
Crossref
Bruno Veigas, Pedro Pedrosa, Isabel Couto, Miguel Viveiros & Pedro V Baptista. (2013) Isothermal DNA amplification coupled to Au-nanoprobes for detection of mutations associated to Rifampicin resistance in Mycobacterium tuberculosis. Journal of Nanobiotechnology 11:1.
Crossref
Diana Machado, João Perdigão, Jorge Ramos, Isabel Couto, Isabel Portugal, Claudia Ritter, Erik C. Boettger & Miguel Viveiros. (2013) High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations. Journal of Antimicrobial Chemotherapy 68:8, pages 1728-1732.
Crossref
Bruno Veigas, Jorge M. Jacob, Mafalda N. Costa, David S. Santos, Miguel Viveiros, João Inácio, Rodrigo Martins, Pedro Barquinha, Elvira Fortunato & Pedro Viana Baptista. (2012) Gold on paper–paper platform for Au-nanoprobe TB detection. Lab on a Chip 12:22, pages 4802.
Crossref
Bruno Veigas, Diana Machado, João Perdigão, Isabel Portugal, Isabel Couto, Miguel Viveiros & Pedro V Baptista. (2010) Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis . Nanotechnology 21:41, pages 415101.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.